The expression of the codon‐optimized Alkal2 transgene was first confirmed in Rosa26_Alkal2;Th‐MYCN tumours (median 1.01 (0.79–1.07) reads per million versus 0 in the other 2 tumour types; Fig 5A). This evidence concerns the gene ALKAL2 and neoplasm.